Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

six TAAs-specific autologous T cells MT-601

A preparation of autologous, ex vivo-expanded, CD4- and CD8-positive T lymphocytes specific for six tumor-associated antigens (TAAs), with potential immunomodulating and antineoplastic activities. Upon administration of six TAAs-specific autologous T cells MT-601, the T cells target, bind to and induce selective toxicity in cancer cells overexpressing one or more of these six TAAs. By targeting more than one antigen, MT-601 may be able to induce a better and more durable anti-tumor response due to its ability to overcome antigen loss.
Synonym:autologous T-cells-targeting six TAAs MT-601
multi-antigen specific CD4+ andCD8+ autologous T cells MT-601
multi-TAA-specific autologous T cells MT-601
multi-tumor-associated antigen-specific autologous T cells MT-601
Code name:MT 601
MT-601
MT601
Search NCI's Drug Dictionary